Mercaptopurine and gastrointestinal haemorrhage Patient Reports February 12, 2012

Mercaptopurine Side Effects Report #5805795-8
Mercaptopurine side effect was reported by a Pharmacist from UNITED STATES on July 09, 2008. Male patient, 61 years of age, weighting 225.1 lb, was diagnosed with inflammatory bowel disease and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood bilirubin unconjugated increased, flatulence, gastritis, gastrointestinal haemorrhage, haematochezia, hypophagia, nausea , pancytopenia. Mercaptopurine dosage: 50 MG BID PO. Patient was hospitalized. Patient recovered.

Mercaptopurine Side Effects Report #5053132-1
Mercaptopurine side effect was reported by a Consumer or non-health professional from CANADA on July 06, 2006. Male patient, 39 years of age, was diagnosed with crohn's disease  and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal haemorrhage, gastrointestinal ulcer, stomach discomfort, white blood cell count decreased. Mercaptopurine dosage: 50 MILLIGRAM ORAL. Patient recovered.

Mercaptopurine Side Effects Report #5073852-2
Mercaptopurine side effect was reported by a Consumer or non-health professional from CANADA on July 26, 2006. Male patient, 39 years of age, was diagnosed with crohn's disease  and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: anaemia, asthenia, gastrointestinal haemorrhage, gastrointestinal ulcer, headache , pharyngolaryngeal pain, white blood cell count decreased. Mercaptopurine dosage: 50 MILLIGRAM ORAL. Patient recovered.

Mercaptopurine Side Effects Report #5457558-3
Mercaptopurine side effect was reported by a Consumer or non-health professional from on Sept 11, 2007. Male patient, 32 years of age, was diagnosed with crohn's disease , abdominal pain , systemic antifungal treatment, infection  and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: abdominal sepsis, gallbladder necrosis, gastric perforation, gastrointestinal haemorrhage, liver abscess, mucormycosis, multi-organ failure, pneumoperitoneum. Mercaptopurine dosage: unknown. During the same period patient was treated with INFLIXIMAB, CORTICOSTEROIDS, ABELCET, BROAD. Patient was hospitalized. Patient died.


Mercaptopurine Side Effects Report #5463784-X
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 05, 2007. Male patient, 32 years of age, was diagnosed with crohn's disease  and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: abdominal pain , abdominal sepsis, candidiasis, enterococcal infection, gallbladder necrosis, gastric perforation, gastrointestinal haemorrhage, haemodynamic instability, large intestine perforation. Mercaptopurine dosage: 75 MG (75 MG, 1 IN 1 D). During the same period patient was treated with INFLIXIMAB, CORTICOSTEROIDS. Patient was hospitalized. Patient died.

Mercaptopurine Side Effects Report #5148653-7
Mercaptopurine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 30, 2006. Female patient was diagnosed with crohn's disease  and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage. Mercaptopurine dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient recovered.

Mercaptopurine Side Effects Report #5110092-2
Mercaptopurine side effect was reported by a Pharmacist from UNITED STATES on Sept 19, 2006. Male patient, 82 years of age, weighting 127.9 lb, was diagnosed with colitis ulcerative, crohn's disease  and was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: asthenia, blood albumin decreased, duodenal ulcer, duodenal ulcer haemorrhage, gastrointestinal haemorrhage, haematocrit decreased, hypotension, intestinal perforation, leukocytosis. Mercaptopurine dosage: 50 MG DAILY PO. During the same period patient was treated with MESALAMINE SA, PREDNISONE, OMEPRAZOLE, RANITIDINE, CIPROFLOXACIN, METRONIDAZOLE. Patient was hospitalized. Patient recovered.

Mercaptopurine Side Effects Report #6060901-8
Mercaptopurine side effect was reported by a Consumer or non-health professional from CANADA on Jan 30, 2009. Male patient, weighting 95.02 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: dialysis , gastrointestinal haemorrhage. Mercaptopurine dosage: 2050 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Mercaptopurine Side Effects Report #6105193-6
Mercaptopurine side effect was reported by a Consumer or non-health professional from CANADA on Mar 04, 2009. Male patient, weighting 95.02 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: bacteria blood identified, caecitis, dialysis , fluid overload, gastrointestinal haemorrhage, hypotension, klebsiella infection, pleural effusion, pneumonitis. Mercaptopurine dosage: 2050 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.


Mercaptopurine Side Effects Report #6108211-4
Mercaptopurine side effect was reported by a Consumer or non-health professional from CANADA on Mar 05, 2009. Male patient, weighting 95.02 lb, was treated with Mercaptopurine. After drug was administered, patient experienced the following side effects: caecitis, fluid overload, gastrointestinal haemorrhage, haemodialysis, hypotension, klebsiella infection, lung infiltration, pleural effusion, pneumonitis. Mercaptopurine dosage: 2050 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.